Symposia

• Novel vistas on the multiple links between mitochondria and mental health
• Inflammation in depression: a bird’s eye view across the body and across the lifespan
• Improving resilience as a therapeutic strategy: from neural mechanisms to pharmacological and artificial intelligence interventions
• Predictive biomarkers for the therapeutic effects of classical psychedelic drugs
• Implementing precision psychiatry in clinical practice: what are we waiting for?
• Prescription digital therapeutics for mental health: where are we going?
• Personalized psychopharmacology in neurodevelopmental disorders
• Molecular pathways to accelerated aging in psychiatric disorders
• The biology behind anorexia nervosa
• Sex impact on pathophysiology of developmental brain disorders
• Towards diagnostic digital health technologies in psychiatry
• Can human genetics findings translate towards clinical practice in psychiatry?
• Exploring the frontiers of pharmaco-fMRI: developments, applications, and challenges
• Sleep endophenotypes in schizophrenia: from high-density EEG to neuronal reprogramming
• In utero manipulations programming neurons for altered offspring behaviour
• Pharmacotherapy in Down syndrome: from early brain development to adult-occurring neurodegeneration
• The nutritional psychiatry of depression
• Obsessive Compulsive Disorder: New insights on the biology and treatment
• Treatment of ADHD across the lifespan: monitoring and predicting outcome
• New Findings Symposium for Early Career Presenters (tba on May 2024)
• New Medication Symposium (tba on May 2024)
• Breaking Hot Topic Symposium (tba on May 2024)

Educational Update Sessions

• Educational Update Session on bipolar disorder
• Virtual reality for assessment and treatment in psychiatry: new findings and future directions
• One mother, two lives: how perinatal interventions can change trajectories for both mothers and children.
• Children and adolescents at high risk for psychosis and affective disorders: characterization and treatment
• Catatonia: aetiology, presentation, assessment and treatment
• Alcohol use disorders - personality dimensions and pharmacological treatments
• Educational Update Session organised together with the EPA (European Psychiatric Association)